FDA Panel Snubs Seroquel as 1st Choice Depression Treatment (HealthDay) » MyHealthPortal.com :: Health information on diabetes, cancer, heart disease, arthritis and etc.

Set a start page | Ad to favorites

Home Page Registration

User panel


Login :

Password :



		Registration Lost password?

Health Conditions

	Cancer
	Hepatitis
	Diabetes
	Heart Disease
	Arthritis
	Obesity
	Insomnia
	Crohn's Disease

	Free Health Offers


		News Archive

		August 2010 (34) July 2010 (15) June 2010 (6) May 2010 (15) April 2010 (55) March 2010 (10) February 2010 (10) January 2010 (89) December 2009 (110) November 2009 (95) October 2009 (205) September 2009 (260) August 2009 (335) July 2009 (303) June 2009 (228) May 2009 (340) April 2009 (345) March 2009 (111) December 2008 (5) October 2008 (1) June 2008 (47) May 2008 (35) April 2008 (89) March 2008 (75) February 2008 (47) January 2008 (85) December 2007 (65) November 2007 (95) October 2007 (132) September 2007 (42) December 1969 (3)

Our Polling

My main cholesterol strategy is:

FDA Panel Snubs Seroquel as 1st Choice Depression Treatment (HealthDay)

HealthDay - WEDNESDAY, April 8 (HealthDay News) -- In a unanimous vote, a
U.S. Food and Drug Administration advisory panel determined Wednesday that
AstraZeneca's antipsychotic drug Seroquel has too many safety concerns to
make it a first-line treatment against depression or anxiety
disorders.

0
1
2
3
4
5

(Votes #: 0)

Dear visitor, You have entered on a site as not registered user. We recommend you to be registered or to enter on a site under the your username.

Other News:

FDA Panel Urges Ban on Vicodin, Percocet (HealthDay)

Advisory panel votes on Crestor as heart attack prevention

Insomnia and Anxiety May Be Genetically Linked (HealthDay)

FDA Approves 'Plan B' Pill for 17-Year-Olds (HealthDay)

Panel Wants FDA To Review Painkillers

Calendar


	Advertising

Home Page | Registration | Disclaimer

Copyright © 2007 My Health Portal. All Rights Reserved.